electroCore

ECOR · NASDAQ

$7.49−$0.14 (−1.83%)TodayMarket closed ·
Prev close $7.63

Latest news

  • News

    Full Transcript: electroCore Q2 2026 Earnings Call

  • Press releaseGlobe Newswire

    electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

  • Press releaseGlobe Newswire

    electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

  • Press releaseGlobe Newswire

    electroCore Announces Second Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation

  • Press releaseGlobe Newswire

    Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

  • Press releaseGlobe Newswire

    electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

  • News

    Earnings Scheduled For May 6, 2026

  • Press releaseGlobe Newswire

    electroCore Announces First Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge

  • Press releaseGlobe Newswire

    electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

  • Press releaseGlobe Newswire

    electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

  • News

    Earnings Scheduled For March 26, 2026

  • News

    Earnings Scheduled For March 19, 2026

  • News

    electroCore Anticipates Reporting FY25 Revenue Of ~$31.8M-$32M; Estimates Q4 Revenue To Be ~$9M-$9.2M

  • Press releaseGlobe Newswire

    electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million

  • News

    Earnings Scheduled For November 5, 2025

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    Earnings Scheduled For August 6, 2025

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseACCESSWIRE

    Ecora Resources PLC Announces Half year results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.